<DOC>
	<DOCNO>NCT01271686</DOCNO>
	<brief_summary>This study evaluate 24-hour IOP-lowering efficacy 0.01 % bimatoprost daily patient glaucoma ocular hypertension</brief_summary>
	<brief_title>24-hour IOP-lowering Effect 0.01 % Bimatoprost</brief_title>
	<detailed_description>Objectives To investigate 24 h effect bimatoprost 0.01 % monotherapy intraocular pressure ( IOP ) ocular perfusion pressure ( OPP ) . Design Prospective , open-label experimental study . Setting Single tertiary ophthalmic clinic . Participants Sixteen patient diagnose primary open-angle glaucoma ( POAG ) ocular hypertension ( age , 49-77 year ) . Interventions Baseline data 24 h IOP untreated patient collect sleep laboratory . Measurements IOP take use pneumatonometer every 2 h sit supine body position 16 h diurnal/wake period supine position 8 h nocturnal/sleep period . After baseline measurement take , patient treat bimatoprost 0.01 % one time per day bedtime 4 week , 24 h IOP data collect laboratory condition . Primary outcome measure nocturnal IOP mean bimatoprost 0.01 % treatment compare baseline .</detailed_description>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>primary openangle glaucoma ocular hypertension Women childbearing potential previous glaucoma surgery presence eye disease</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>